This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Nutrien's (NTR) Earnings and Revenues Lag Estimates in Q2
by Zacks Equity Research
Nutrien (NTR) gains on higher selling prices and strong Retail performance in Q2 amid headwinds from weak volumes in North America and higher natural gas costs.
Are Basic Materials Stocks Lagging Nutrien (NTR) This Year?
by Zacks Equity Research
Here is how Nutrien (NTR) and SQM (SQM) have performed compared to their sector so far this year.
Nutrien (NTR) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of -0.85% and 5.56%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Nutrien (NTR) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Nutrien (NTR) second-quarter performance is likely to reflect higher prices and increased demand for crop nutrients.
Zacks Industry Outlook Highlights Nutrien, Sociedad Quimica y Minera de Chile S.A., CF Industries Holdings and Intrepid Potash
by Zacks Equity Research
Nutrien, Sociedad Quimica y Minera de Chile S.A., CF Industries Holdings and Intrepid Potash are part of Zacks Industry Outlook article.
CF Industries (CF) Q2 Earnings Beat Estimates
by Zacks Equity Research
CF (CF) delivered earnings and revenue surprises of 2.15% and 6.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is CF Industries (CF) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Top Fertilizer Stocks to Ride the Industry's Momentum
by Anindya Barman
Strong demand and pricing dynamics for crop nutrients aided by favorable global agriculture markets should help the Zacks Fertilizers industry to thrive. NTR, SQM, CF and IPI are poised to gain from solid industry fundamentals.
Nutrien (NTR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Nutrien (NTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Intrepid Potash (IPI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Most-Watched Stock Nutrien Ltd. (NTR) Worth Betting on Now?
by Zacks Equity Research
Zacks.com users have recently been watching Nutrien (NTR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is Nutrien (NTR) Stock Outpacing Its Basic Materials Peers This Year?
by Zacks Equity Research
Here is how Nutrien (NTR) and SQM (SQM) have performed compared to their sector so far this year.
Are Options Traders Betting on a Big Move in Nutrien (NTR) Stock?
by Zacks Equity Research
Investors need to pay close attention to Nutrien (NTR) stock based on the movements in the options market lately.
Nutrien (NTR) Benefits From Demand Strength Amid Cost Woes
by Zacks Equity Research
While Nutrien (NTR) is exposed to cost inflation, it is benefiting from solid demand and higher prices for fertilizers, backed by the strength in global agriculture markets.
Nutrien (NTR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Nutrien (NTR) closed the most recent trading day at $74.42, moving -1.74% from the previous trading session.
Nutrien Ltd. (NTR) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Nutrien (NTR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Celanese (CE) Prices $7.5B Financing for DuPont M&M Buyout
by Zacks Equity Research
Celanese (CE) enters into a cross-currency swap to convert $2.5 billion of the U.S. dollar-denominated notes into euro-denominated borrowing at prevailing euro interest rates.
What Makes Ashland (ASH) Stock a Solid Choice Right Now
by Zacks Equity Research
Ashland (ASH) benefits from strong demand in most consumer end markets and its pricing actions to counter inflation.
Univar (UNVR) Gains on Cost Reductions and Acquisitions
by Zacks Equity Research
Univar (UNVR) is benefiting from cost actions, market expansion and synergies of the Nexeo Solutions acquisition.
Air Products (APD) Inks Joint Development Deal With VPI
by Zacks Equity Research
Air Products' (APD) deal with VPI marks a major step that will likely bring several new jobs to the region during construction and operation.
Is Nutrien (NTR) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Down 16.1% in 4 Weeks, Here's Why Nutrien (NTR) Looks Ripe for a Turnaround
by Zacks Equity Research
Nutrien (NTR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Nutrien (NTR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Nutrien (NTR) closed at $74.12, marking a -0.74% move from the previous day.
Newmont (NEM) Inks Profit-Sharing Deal With Penasquito Union
by Zacks Equity Research
Newmont (NEM) Penasquito will pay its represented workforce an uncapped profit-sharing bonus of up to 10% in-line with other agreements across Mexico.
Here's Why You Should Retain FMC Corp (FMC) in Your Portfolio
by Zacks Equity Research
FMC Corp (FMC) gains on healthy demand for its products, price increase actions and efforts to strengthening its product portfolio.